Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01454882 · ClinicalTrials.gov registry record
Measuring Free-living Energy Expenditure Using Direct Calorimetry
A clinical trial, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- 39
- Enrollment target
NCT01454882: Completed study, sponsored by University of Colorado, Denver.
NCT01454882 is a clinical trial that has completed, run by University of Colorado, Denver. The registered enrollment target is 39 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01454882 has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- 39 participants
- Enrollment target
Study Summary
Although instruments such as pedometers and heart rate monitors are helpful for those who use exercise to maintain their weight, they do not actually measure calories expended, which is a critical piece of information necessary for sustained weight management. The purpose of this study is to determine the accuracy of a new device that measures calories burned based upon heat produced by the body. Since heat production is directly proportional to calories burned, this device has the potential to accurately measure energy expended in many different settings.
Primary Outcome
The aim of this trial is to determine the accuracy of measuring energy expenditure using portable direct calorimetry. Energy expenditure will be measured with a new device worn on the arm that measures heat flux. The accuracy of the new device will be compared against simultaneous measurements of energy expenditure made using indirect calorimetry and doubly labeled water.
Interventions
- BEHAVIORAL Effects of Clothing
- BEHAVIORAL Effects of Temperature
- BEHAVIORAL Low Physical Activity
- BEHAVIORAL High Physical Activity
- BEHAVIORAL Direct calorimetry and doubly labeled water
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2012-01 |
| Est. Completion | 2016-01 |
What the finished NCT01454882 record still lists
NCT01454882 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 39 participants, a relatively small participant target.
The record links to 0 conditions, and to 5 interventions - of which Effects of Clothing is the first listed.
NCT01454882 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01454882 about?
NCT01454882 is a clinical study titled "Measuring Free-living Energy Expenditure Using Direct Calorimetry". Although instruments such as pedometers and heart rate monitors are helpful for those who use exercise to maintain their weight, they do not actually measure calories expended, which is a critical piece of information necessary for sustained weight management. The purpose of this study is to determi...
What is the current status of trial NCT01454882?
This trial is currently completed. The enrollment target is 39 participants. The study started on 2012-01. Estimated completion is 2016-01.
What interventions are being tested in trial NCT01454882?
The interventions under investigation include: Effects of Clothing (BEHAVIORAL), Effects of Temperature (BEHAVIORAL), Low Physical Activity (BEHAVIORAL), High Physical Activity (BEHAVIORAL), Direct calorimetry and doubly labeled water (BEHAVIORAL).
Who is sponsoring clinical trial NCT01454882?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03465592 · 39 participants · Phase 1
Trial of Nivolumab Following Partially Human Leukocyte Antigen (HLA) Mismatched BMT in Children & Adults With Sarcoma
- NCT03961776 · 39 participants
Monitoring Treatment Response With On-board DWI During Neo-adjuvant Chemo-radiation for Rectal Cancer Using Magnetic Resonance-guided-radiotherapy Systems
- NCT04050280 · 39 participants · Phase 2
CLAG-GO for Patients With Persistent, Relapsed or Refractory AML
- NCT04190862 · 39 participants · Phase 1
E-CEL UVEC as an Adjunct Cell Therapy for Treatment of Anal Fistulas
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia